• "It is not a medicine. You don't know what's in it. If there were compelling scientific and medical data supporting marijuana's medical benefits that would be one thing. But the data is not there." (10/04)

• "As a crude plant, marijuana is so complex, unstable, and harmful that sensible physicians and researchers consider it unethical to expose individuals to the risks associated with smoking it." (2/17/04)

 Key Experts
Physicians [We believe physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.].

• 2005-Present -- Founder and Chief Executive Officer of EMGlobal LLC, a global health care and policy-consulting firm
• 2005-Present -- consultant to GW Pharmaceuticals & Bayer to win approval for Sativex in the U.S.
• Board of Directors, Coalition to End Needless Death on Our Roadways (END)
• 2002-2005 -- Deputy Director for Demand Reduction, White House Office of National Drug Control Policy (ONDCP)
• Founding Member, Chicago Area AIDS Task Force
• Past President, American Society of Addiction Medicine

• Post-graduate training, University of Chicago & Northwestern University Medical Center
• M.D., University of Michigan Medical School
• B.A., Psychology, Wesleyan University

• 2003, Betty Ford Award
• Member, White House Task Force on Disadvantaged Youth
• Member, White House Domestic Violence Working Group